A
3.79
-0.09 (-2.32%)
| Penutupan Terdahulu | 3.88 |
| Buka | 3.86 |
| Jumlah Dagangan | 86,572 |
| Purata Dagangan (3B) | 509,384 |
| Modal Pasaran | 1,180,968,320 |
| Harga / Pendapatan (P/E TTM) | 16.48 |
| Harga / Pendapatan (P/E Ke hadapan) | 8.21 |
| Harga / Jualan (P/S) | 2.01 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 18 Mar 2026 |
| Margin Keuntungan | 16.42% |
| Margin Operasi (TTM) | 7.97% |
| EPS Cair (TTM) | 0.370 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 260.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -65.50% |
| Nisbah Semasa (MRQ) | 1.73 |
| Aliran Tunai Operasi (OCF TTM) | -148.89 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -216.76 M |
| Pulangan Atas Aset (ROA TTM) | 7.02% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Alvotech | Menurun | Menurun |
AISkor Stockmoo
-1.4
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | -2.5 |
| Purata | -1.38 |
|
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 63.44% |
| % Dimiliki oleh Institusi | 6.44% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Littlejohn & Co Llc | 31 Dec 2025 | 1,318,534 |
| Pointstate Capital Lp | 31 Dec 2025 | 1,049,039 |
| Lodbrok Capital Llp | 30 Sep 2025 | 181,587 |
| Oaktree Fund Advisors, Llc | 31 Dec 2025 | 146,843 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |